Latest Regulatory Filings News

Page 10 of 13
Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.
Ada Torres
Ada Torres
11 July 2025
Laramide Resources has expanded its private placement to raise up to $12 million, aiming to fast-track US permitting and strengthen its balance sheet. The move signals confidence in advancing its late-stage uranium projects amid a competitive market.
Maxwell Dee
Maxwell Dee
8 July 2025
Findi Limited is applying for two key licences from the Reserve Bank of India to expand its digital payments footprint, aiming to bridge the gap between cash and digital economies across India.
Claire Turing
Claire Turing
2 July 2025
Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.
Ada Torres
Ada Torres
1 July 2025
Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.
Ada Torres
Ada Torres
1 July 2025
PointsBet Holdings has dismissed allegations from Betr Entertainment regarding vote exclusion in its recent Scheme of Arrangement meeting, confirming the scheme’s approval and setting the stage for a crucial court hearing.
Claire Turing
Claire Turing
25 June 2025
Cleo Diagnostics has gained approval to access the prestigious PLCO biobank, a move set to strengthen its FDA submission and accelerate development of its ovarian cancer diagnostic tests.
Ada Torres
Ada Torres
25 June 2025
Solis Minerals has voluntarily delisted from the TSX Venture Exchange to concentrate on its primary ASX listing, prompting changes to its ASX waivers and financial reporting calendar.
Maxwell Dee
Maxwell Dee
25 June 2025
Rhythm Biosciences has regained NATA accreditation for its geneType laboratory, a key step toward commercialising its ColoSTAT® cancer risk test as an in-house diagnostic.
Ada Torres
Ada Torres
24 June 2025
Findi Limited has appointed DAM Capital and Ambit as lead managers for the IPO of its Indian subsidiary, Transaction Solutions International, targeting a valuation near A$900 million and a 2026 listing.
Claire Turing
Claire Turing
24 June 2025
Brookside Energy has expanded its SWISH Play acreage in Oklahoma's Anadarko Basin by adding a fifth Drilling Spacing Unit, increasing its high-impact drilling inventory by over a quarter. This move strengthens its development pipeline ahead of a planned NYSE listing.
Maxwell Dee
Maxwell Dee
24 June 2025
Shift4 Payments, LLC has entered into a definitive scheme implementation agreement to acquire Smartpay Holdings Limited at NZ$1.20 per share, subject to regulatory and shareholder approvals. The transaction outlines a detailed timetable and conditions, including Overseas Investment Office consent and court sanction.
Claire Turing
Claire Turing
23 June 2025